<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">

<head>
<meta content="text/html; charset=windows-1256" http-equiv="Content-Type" />
<title>NURSING DIAGNOSIS</title>
</head>

<body>

<h2 style="font-size: 16pt; font-weight: bold; color: rgb(51, 0, 153); font-family: Verdana, Arial, Helvetica, sans-serif; font-style: normal; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px;">
NURSING DIAGNOSIS: Decreased cardiac output</h2>
<strong class="sm" style="font-weight: bold; font-size: 8pt; color: rgb(0, 0, 0); font-family: Verdana, Arial, Helvetica, sans-serif; font-style: normal; font-variant: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px;">
related to alterations in preload, afterload, and myocardial contractility 
associated with:<ol style="list-style: decimal;" type="A">
	<li>the cardiac condition causing the heart failure (e.g. ischemia of the 
	myocardium, valve malfunction, cardiomyopathy);</li>
	<li>the effects of sympathetic nervous system and 
	renin-angiotensin-aldosterone stimulation that occur in response to 
	decreased cardiac output;</li>
	<li>structural changes in the heart (e.g. dilation, hypertrophy, spherical 
	shape) that occur with prolonged activation of neurohormonal adaptive 
	responses.</li>
</ol>
</strong>
<table bgcolor="#DDDDDD" style="font-family: Verdana, Arial, Helvetica, sans-serif; letter-spacing: normal; orphans: auto; text-indent: 0px; text-transform: none; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px;">
	<tr>
		<th class="subhead" style="font-weight: bold; color: rgb(255, 255, 255); padding: 2px; margin: 0px; border: none; font-size: 11pt; background-color: rgb(51, 0, 153);">
		Desired Outcome</th>
	</tr>
	<tr>
		<td>The client will have improved cardiac output as evidenced by:<ol style="list-style: decimal;" type="a">
			<li>B/P within normal range for client</li>
			<li>apical pulse between 60 - 100 beats/minute and regular</li>
			<li>resolution of gallop rhythm</li>
			<li>verbalization of feeling less fatigued and weak</li>
			<li>unlabored respirations at 12 - 20/minute</li>
			<li>improved breath sounds</li>
			<li>usual mental status</li>
			<li>absence of dizziness and syncope</li>
			<li>palpable peripheral pulses</li>
			<li>skin warm and usual color</li>
			<li>capillary refill time less than 3 seconds</li>
			<li>urine output at least 30 ml/hour</li>
			<li>decrease in edema and jugular vein distention</li>
			<li>central venous pressure (CVP) within normal range.</li>
		</ol>
		</td>
	</tr>
</table>
<table style="font-family: Verdana, Arial, Helvetica, sans-serif; letter-spacing: normal; orphans: auto; text-indent: 0px; text-transform: none; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px;">
	<tr>
		<th class="subhead" style="font-weight: bold; color: rgb(255, 255, 255); padding: 2px; margin: 0px; border: none; font-size: 11pt; background-color: rgb(51, 0, 153);">
		Nursing Actions and<span class="Apple-converted-space">&nbsp;</span><em class="purpose" style="font-style: italic;">Selected 
		Purposes/Rationales</em></th>
	</tr>
</table>
<ol style="list-style: decimal; color: rgb(0, 0, 0); font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px;" type="A">
	<li>Assess for signs and symptoms of heart failure and decreased cardiac 
	output:<ol style="list-style: upper-alpha;" type="1">
		<li>variations in B/P (may be increased because of compensatory 
		vasoconstriction; may be decreased when compensatory mechanisms and pump 
		fail)</li>
		<li>tachycardia</li>
		<li>pulsus alternans (alternating strong and weak pulse)</li>
		<li>presence of an S<sub style="font-size: 9pt;">3</sub><span class="Apple-converted-space">&nbsp;</span>heart 
		sound</li>
		<li>fatigue and weakness</li>
		<li>dyspnea, orthopnea, tachypnea</li>
		<li>dry, hacking cough or cough productive of frothy or blood-tinged 
		sputum</li>
		<li>abnormal breath sounds (e.g. crackles [rales], wheezes, diminished 
		sounds)</li>
		<li>restlessness, change in mental status</li>
		<li>dizziness, syncope</li>
		<li>diminished or absent peripheral pulses</li>
		<li>cool extremities</li>
		<li>pallor or cyanosis of skin</li>
		<li>capillary refill time greater than 3 seconds</li>
		<li>decreased urine output during day, nocturia</li>
		<li>edema</li>
		<li>jugular vein distention (JVD)</li>
		<li>increased CVP (use internal jugular vein pulsation method to 
		estimate CVP if monitoring device not present)</li>
		<li>chest x-ray results showing pulmonary vascular congestion, pleural 
		effusion, or pulmonary edema.</li>
	</ol>
	</li>
	<li>Implement measures<span class="Apple-converted-space">&nbsp;</span><em class="purpose" style="font-style: italic;">to 
	improve cardiac output:</em><ol style="list-style: upper-alpha;" type="1">
		<li>perform actions<span class="Apple-converted-space">&nbsp;</span><em class="purpose" style="font-style: italic;">to 
		reduce cardiac workload:</em><ol style="list-style: upper-roman;" type="a">
			<li>place client in a semi- to high Fowler's position</li>
			<li>instruct client to avoid activities that create a Valsalva 
			response (e.g. straining to have a bowel movement, holding breath 
			while moving up in bed)</li>
			<li>implement measures<span class="Apple-converted-space">&nbsp;</span><em class="purpose" style="font-style: italic;">to 
			promote emotional and physical rest</em><span class="Apple-converted-space">&nbsp;</span>(e.g. 
			maintain a calm, quiet environment; limit the number of visitors; 
			maintain activity restrictions)</li>
			<li>implement measures to improve respiratory status (see Diagnosis 
			2, action b)<span class="Apple-converted-space">&nbsp;</span><em class="purpose" style="font-style: italic;">in 
			order to improve alveolar gas exchange and promote adequate tissue 
			oxygenation</em></li>
			<li>discourage smoking (<em class="purpose" style="font-style: italic;">nicotine 
			has a cardiostimulatory effect and causes vasoconstriction; the 
			carbon monoxide in smoke reduces oxygen availability</em>)</li>
			<li>provide small meals rather than large ones (<em class="purpose" style="font-style: italic;">large 
			meals can increase cardiac workload because they require a greater 
			increase in blood supply to gastrointestinal tract for digestion</em>)</li>
			<li>discourage excessive intake of beverages high in caffeine such 
			as coffee, tea, and colas (<em class="purpose" style="font-style: italic;">caffeine 
			is a myocardial stimulant and can increase myocardial oxygen 
			consumption</em>)</li>
			<li>increase activity gradually as allowed and tolerated</li>
			<li>implement measures to reduce fluid volume excess (see Diagnosis 
			3, action D.1)</li>
		</ol>
		</li>
		<li>administer the following medications if ordered:<ol style="list-style: upper-roman;" type="a">
			<li>diuretics (e.g. furosemide, torsemide, bumetanide, 
			spironalactone, metolazone)<span class="Apple-converted-space">&nbsp;</span><em class="purpose" style="font-style: italic;">to 
			reduce sodium and water retention and subsequently reduce cardiac 
			workload</em></li>
			<li>angiotensin-converting enzyme (ACE) inhibitors (e.g. captopril, 
			ramipril, enalapril, lisinopril)<span class="Apple-converted-space">&nbsp;</span><em class="purpose" style="font-style: italic;">to 
			reduce vascular resistance and subsequently decrease cardiac 
			workload; they also alter the course of cardiac remodeling and slow 
			disease progression</em></li>
			<li>positive inotropic agents (e.g. digoxin, dopamine, dobutamine)<span class="Apple-converted-space">&nbsp;</span><em class="purpose" style="font-style: italic;">to 
			improve myocardial contractility</em></li>
			<li>beta-adrenergic blocking agents (e.g. carvedilol)<span class="Apple-converted-space">&nbsp;</span><em class="purpose" style="font-style: italic;">to 
			blunt the effects of the sympathetic nervous system stimulation that 
			occurs and subsequently improve the clinical status and course of 
			the disease.</em></li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Consult physician if signs and symptoms of decreased cardiac output 
	persist or worsen.</li>
</ol>
<br class="Apple-interchange-newline" />

</body>

</html>
